HUT64695A - Method for production of preparations containing nicotinyl-alanine for the treatment of central nervous system (cns) diseares - Google Patents
Method for production of preparations containing nicotinyl-alanine for the treatment of central nervous system (cns) diseares Download PDFInfo
- Publication number
- HUT64695A HUT64695A HU9203634A HU363492A HUT64695A HU T64695 A HUT64695 A HU T64695A HU 9203634 A HU9203634 A HU 9203634A HU 363492 A HU363492 A HU 363492A HU T64695 A HUT64695 A HU T64695A
- Authority
- HU
- Hungary
- Prior art keywords
- nicotinylalanine
- treatment
- nicotinyl
- alanine
- compound
- Prior art date
Links
- WAEJUYSDAMMJMI-UHFFFAOYSA-N CC(c(cccc1)c1NC=O)=O Chemical compound CC(c(cccc1)c1NC=O)=O WAEJUYSDAMMJMI-UHFFFAOYSA-N 0.000 description 1
- VYDHWHUAIFIMGM-SREVYHEPSA-N Cc1ccccc1/C=C\N Chemical compound Cc1ccccc1/C=C\N VYDHWHUAIFIMGM-SREVYHEPSA-N 0.000 description 1
- BOOQPWXVCDYIJP-UHFFFAOYSA-N NC(CC(c1cnccc1)=O)C(O)=O Chemical compound NC(CC(c1cnccc1)=O)C(O)=O BOOQPWXVCDYIJP-UHFFFAOYSA-N 0.000 description 1
- 0 OC(*Cc1c[n]c2ccccc12)=O Chemical compound OC(*Cc1c[n]c2ccccc12)=O 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT02041890A IT1248486B (it) | 1990-05-24 | 1990-05-24 | Agente terapeutico ad attivita' sul sistema nervoso centrale |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9203634D0 HU9203634D0 (en) | 1993-03-29 |
| HUT64695A true HUT64695A (en) | 1994-02-28 |
Family
ID=11166634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9203634A HUT64695A (en) | 1990-05-24 | 1991-05-21 | Method for production of preparations containing nicotinyl-alanine for the treatment of central nervous system (cns) diseares |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0532545A1 (it) |
| JP (1) | JPH05507086A (it) |
| AU (1) | AU7883291A (it) |
| BR (1) | BR9106500A (it) |
| CA (1) | CA2083507A1 (it) |
| HU (1) | HUT64695A (it) |
| IT (1) | IT1248486B (it) |
| WO (1) | WO1991017750A1 (it) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0684238A3 (en) * | 1994-04-27 | 1997-01-15 | Hoffmann La Roche | Process for the preparation of dicarboxamides. |
| US5536867A (en) * | 1994-04-27 | 1996-07-16 | Hoffmann-La Roche Inc. | Process for the manufacture of dicarboxamides |
| JPH11501934A (ja) * | 1995-03-14 | 1999-02-16 | シャスカン，エドワード・ジー | ニコチニルアラニンと、グリシン抱合の阻害薬又はビタミンｂ６とを含む組成物 |
| PE20201169A1 (es) * | 2017-09-28 | 2020-10-28 | Lg Chemical Ltd | Metodo de produccion de un compuesto intermedio para sintetizar un medicamento |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3649649A (en) * | 1967-07-10 | 1972-03-14 | Nisso Kako Co Ltd | Fluoran derivatives and preparation thereof |
| FR1596106A (it) * | 1968-12-13 | 1970-06-15 | ||
| US4065566A (en) * | 1975-04-17 | 1977-12-27 | Interx Research Corporation | N-Nicotinoyl-3,4-dinicotinoyloxy-L-phenylalanine and derivatives pharmaceutical compositions and methods containing same |
-
1990
- 1990-05-24 IT IT02041890A patent/IT1248486B/it active IP Right Grant
-
1991
- 1991-05-21 CA CA002083507A patent/CA2083507A1/en not_active Abandoned
- 1991-05-21 WO PCT/EP1991/000950 patent/WO1991017750A1/en not_active Ceased
- 1991-05-21 BR BR919106500A patent/BR9106500A/pt unknown
- 1991-05-21 HU HU9203634A patent/HUT64695A/hu unknown
- 1991-05-21 JP JP91509723A patent/JPH05507086A/ja active Pending
- 1991-05-21 EP EP91909910A patent/EP0532545A1/en not_active Withdrawn
- 1991-05-21 AU AU78832/91A patent/AU7883291A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR9106500A (pt) | 1993-05-25 |
| IT1248486B (it) | 1995-01-19 |
| EP0532545A1 (en) | 1993-03-24 |
| IT9020418A1 (it) | 1991-11-24 |
| HU9203634D0 (en) | 1993-03-29 |
| WO1991017750A1 (en) | 1991-11-28 |
| IT9020418A0 (it) | 1990-05-24 |
| AU7883291A (en) | 1991-12-10 |
| JPH05507086A (ja) | 1993-10-14 |
| CA2083507A1 (en) | 1991-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2756756B2 (ja) | ペンタン酸誘導体、その製造方法およびそれらを含有する薬剤 | |
| KR100191050B1 (ko) | 산화질소의 생합성 억제제 | |
| CA2517893C (fr) | Application a titre de medicaments de derives de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation | |
| JP2001511172A (ja) | 特に神経興奮薬性アミノ酸に感受性をもつ中枢神経系受容体のエフェクターを構成する化合物、その製造およびその生物学的利用 | |
| KR20190006012A (ko) | 소베티롬의 유도체 | |
| JP2017141257A (ja) | 神経系の障害の処置のためのパントテン酸誘導体 | |
| EP0663899B1 (en) | Substituted kynurenines, a process for their preparation, and use as medicaments | |
| PT776201E (pt) | Composicao e metodo para tratar a ansiedade | |
| JPH051780B2 (it) | ||
| JP3618104B2 (ja) | 薬物依存症に対する保護のための組成物及び方法 | |
| HU211732B (en) | Process to prepare 2-hydroxy-2-phenylethylamino compounds and pharmaceutical comns. contg. them | |
| EP0532545A1 (en) | Nicotinylalanine as a therapeutic agent acting on the central nervous system | |
| EP0723969B1 (de) | Phosphonocarbonsäure-Derivate und deren Verwendung zur Behandlung von degenerativen Gelenkserkrankungen | |
| JP7295145B2 (ja) | 神経変性疾患を治療するための医薬及びその使用 | |
| EP1165089A1 (fr) | Utilisation de la tianeptine pour l'obtention de medicaments destines au traitement des pathologies de la neurodegenerescence | |
| JP2001523659A (ja) | 細胞外グルタミン酸濃度を低下させるための４位置換２−ピロリジノン誘導体 | |
| KR890002771B1 (ko) | Mao 억제제의 제조방법 | |
| EP1853556A1 (en) | Derivatives of aminobutanoic acid inhibiting cpt | |
| US9296702B2 (en) | Rosuvastatin enantiomer compounds | |
| US4042584A (en) | Ethynylaryl phenyl cyclopropyl thiazines and morpholines | |
| US5786508A (en) | Substituted kynurenines and process for their preparation | |
| CN121202810A (zh) | 一种苯并硫氮杂卓类化合物、其制备方法及用途 | |
| JPS6383020A (ja) | 中枢性神経退行性疾患の進行防止および治療剤 | |
| JPH0733656A (ja) | 免疫賦活剤 | |
| JP2006516248A (ja) | クローゼンアミドのｃ５−ヒドロキシル誘導体およびｎ−置換誘導体、その製法、医薬組成物および使用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFD9 | Temporary protection cancelled due to non-payment of fee |